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Abstract
The definitive diagnosis of spotted fever group (SFG) rickettsioses in humans is challenging due to 
the retrospective nature and cross reactivity of the serological methods and the absence of reliable 
and consistent samples for molecular diagnostics. Existing data indicate the transient character of 
bacteremia in experimentally infected animals. The ability of arthropod vectors to acquire 
rickettsial infection from the laboratory animals in the absence of systemic infection and known 
tropism of rickettsial agents to endothelial cells of peripheral blood vessels underline the 
importance of local infection and consequently the diagnostic potential of skin samples. In order to 
evaluate the diagnostic sensitivity of rickettsial DNA detection in blood and skin samples, we 
compared results of PCR testing in parallel samples collected from model laboratory animals 
infected with Rickettsia rickettsii, Rickettsia parkeri and Rickettsia slovaca-like agent at different 
time points after infection. Skin samples were collected from ears – away from the site of tick 
placement and without eschars. Overall, testing of skin samples resulted in a higher proportion of 
positive results than testing of blood samples. Presented data from model animals demonstrates 
that testing of skin samples from sites of rickettsial proliferation can provide definitive molecular 
diagnosis of up to 60–70% of tick-borne SFG rickettsial infections during the acute stage of 
illness. Detection of pathogen DNA in cutaneous samples is a valuable alternative to blood-PCR at 
least in model animals.
Keywords
Rocky Mountain spotted fever; Spotted fever rickettsiosis; Diagnosis; Skin biopsies; Guinea pig
1. Introduction
Spotted fever group (SFG) of the genus Rickettsia consists of a large number of diverse 
arthropod-borne intracellular bacterial species described worldwide and maintained by fleas, 
ticks, and mites. The list includes endosymbiotic bacteria of the arthropod vectors as well as 
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known pathogens, causing spotted fever group rickettsioses (Walker 1989). At least 9 named 
SFG Rickettsia species are endemic to the United States (Denison et al., 2014). Rocky 
Mountain spotted fever (RMSF) caused by Rickettsia rickettsii is the most severe rickettsial 
illness of humans distributed throughout North, Central, and South America. It is transmitted 
by tick vectors, including Dermacentor variabilis, Dermacentor andersoni (in North 
America), several Amblyomma spp. (in Mexico, Central and South America), and 
Rhipicephalus sanguineus s.l. Rickettsia parkeri transmitted by Amblyomma maculatum is 
distributed throughout the southeastern and mid-Atlantic United States. It causes moderately 
severe illness, which shares features with both RMSF and rickettsial pox, including a 
maculopapular rash and the occurrence of inoculation eschars (Paddock et al., 2008). 
Rickettsia slovaca-like agent has recently been found in and isolated from D. variabilis ticks 
(Killmaster et al., 2016). Pathogenicity of this agent in humans has not been established, but 
it causes mostly subclinical infection in guinea pigs (Zemtsova et al., 2016). Domestic and 
synanthropic animals are exposed to and infected with rickettsial pathogens as well and may 
serve as sentinels for assessment of the human risk (Walker 1989; Case et al., 2006; 
Milagres et al., 2010; McQuiston et al., 2011; Pacheco et al., 2011).
Both diagnosis and surveys of rickettsial infections in domestic animals currently rely 
primarily on serology (Breitschwerdt et al., 1985; Maggi et al., 2014), just like the clinical 
diagnosis in humans, where at least 4-fold increase in titers is expected between acute and 
convalescent serum samples (Chapman et al., 2006). Because it normally takes several 
weeks from the onset of the disease for the antibody titers to reach diagnostic levels, 
serological diagnosis is retrospective and provides a confirmation of rickettsial infection 
only after the patient’s recovery or postmortem. Moreover, pathogen species identification is 
complicated by serological cross reactivity between SFG Rickettsia spp. Molecular methods 
are capable of providing better specificity, as well as real-time diagnosis of clinical cases. 
When molecular diagnosis of RMSF is attempted, it is usually done using acute-stage blood 
samples. However, SFG rickettsiae primarily target endothelial cells and normally do not 
infect the circulating blood cells. For example in dogs infected with SFG agents either 
experimentally or naturally, rickettsial DNA may be detected in the blood only intermittently 
(Labruna et al., 2009; Levin et al., 2012; Levin et al., 2014). Periods when rickettsial DNA is 
detectable in the blood of infected in animals are be short in duration, not consistent with the 
dynamic or severity of clinical symptoms, and is affected by external factors such as 
initiation of antibiotic treatment (Labruna et al., 2009; Levin et al., 2014). On the other hand, 
the fact that naïve ticks acquire Rickettsia from infected laboratory animals while the 
presence of rickettsial DNA cannot be detected by blood-PCR and feeding distantly from the 
infected ticks, emphasizes the importance of infection in the skin and local mechanisms in 
rickettsial horizontal transmission (Zemtsova et al., 2010). This corresponds with the 
previous observation that immunostaining of skin biopsy specimens of rash lesions can 
identify rickettsiae in 70% of human RMSF patients while blood-PCR was “unacceptably 
insensitive” (Walker 1995).
Detection of rickettsial DNA has been increasingly reported using eschar tissues or swabs of 
eschars, although the diagnostic sensitivity of these types of specimens in comparison with 
traditional blood samples has not been ascertained (Lakos 2002; Wang et al., 2009; Bechah 
et al., 2011; Mouffok et al., 2011; Myers et al., 2013). Yet, R. rickettsii infections are not 
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usually associated with inoculation eschars, which are rarely observed even in human RMSF 
patients (Walker et al., 1981; Chen and Sexton 2008), where they would be easier to find 
than in fur covered animals.
Here we assess whether rickettsial DNA may be identified in skin samples not associated 
with either eschar, or the site of tick attachment and compare the diagnostic sensitivity of 
rickettsial DNA detection between blood and skin samples, using guinea pigs as model 
animals.
2. Materials and methods
Animal studies were conducted at a facility fully-accredited by the Association for the 
Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. All 
procedures and husbandry were performed in accordance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals (8th edition). Animal protocols were pre-
approved by the Centers for Disease Control Institutional Animal Care and Use Committee 
(IACUC) and monitored by a veterinarian stationed on-site.
Analyses presented here combine PCR results from animals used for multiple studies in 
vector and reservoir competence of SFG Rickettsia spp. The choice of pathogen isolates and 
the inoculation dosages had been adjusted so not to cause any mortality in the model 
animals. Therefore, presented results are from cases of relatively mild, nonlethal, or 
subclinical rickettsial infections.
One to two month-old specific pathogen free male Hartley guinea pigs weighing 400–500 g 
were acquired from Charles River Laboratories (http://www.criver.com). Animals were 
infected with R. rickettsii (isolates BSF-Di6 and AZ3), R. parkeri (isolate Longleaf), or R. 
slovaca-like agent (D. variabilis isolate (Killmaster et al., 2016). Pathogens were introduced 
either via a tick-bite or through the needle-inoculation route – intraperitoneally. For tick-
borne infections, guinea pigs were exposed to 10–20 nymphal ticks (30–50% prevalence of 
infection) placed into feeding bags glued onto animals’ backs. Needle-inoculated animals 
were each injected with spleen/liver tissue homogenate containing a standard infectious dose 
of 105 DNA copies of a specific Rickettsia sp. Tissue homogenates were prepared by 
grinding liver and spleen of previously infected guinea pigs in Snider-1 buffer (20% tissue 
suspension) and cryopreserved in liquid nitrogen as inoculation-ready aliquots until used.
Guinea pigs were observed for the duration of one to three weeks depending on the goal of 
an individual study. During the observation period, the core temperature and signs of 
infection of each animal was recorded daily. In guinea pigs infected with R. rick-ettsii, the 
core temperature usually rose above 39.5 °C at 5–9 days after infection depending on the 
strain of the pathogen and the mode of infection; and the fever period lasted for 2–7 days. 
Majority of guinea pigs infected with either R. parkeri or R. slovaca-like agent exhibited 
only subfebrile temperatures.
Paired blood and skin samples were collected for PCR 2–3 times per week. Skin samples 
consisted of 2 mm punch biopsies weighing 2 mg taken from an ear, and EDTA-
anticoagulated blood samples (100 µl) were collected from a lacerated ear vein. At the end 
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of each individual study, all guinea pigs were euthanized and 5 mg samples of internal 
organs (liver, spleen, and lung) were also collected for PCR. Blood, skin, and internal tissue 
samples were immediately stored at −20 °C until DNA extraction. DNA from skin and 
internal tissues was extracted using the DNeasy Blood & Tissue kit, and DNA from blood 
samples was extracted with FlexiGene DNA Kit (Qiagen, Gaithersburg, Maryland, USA) 
according to the manufacturer’s protocols with the final elution volume of 100 µl for all 
samples. The presence of rickettsial DNA was detected by SYBR green-based PCR assay 
targeting a 154-bp fragment of the rOmpA gene as described (Eremeeva et al., 2003). All 
samples were tested in duplicates using 5 µl of the eluted DNA for each reaction. 
Accordingly, DNA equivalents of 5 µl of whole blood, 0.1 mg of skin tissue, 0.5 mg of 
internal tissues were represented in each PCR reaction.
In addition, a serum sample was collected from each animal at the end of the study and 
tested by IFA for the presence of anti-rickettsial IgG antibodies to confirm an infection. IFA 
was per-formed on guinea pig sera using FITC labeled goat anti-guinea pig IgG (γ) 
conjugate diluted per manufacturer’s recommendations (KPL, Inc. Gaithersburg, Maryland, 
USA) and homologous rickettsial antigens.
Proportions of positive skin and blood samples per day post-infection (DPI) were compared 
using the paired t-test with the hypothesized mean difference = 0 and α = 0.05.
3. Results
For the purpose of the current comparative analysis, we removed from the data sets any 
animals that did not become infected as well as all asynchronous samples when both the 
blood and skin biopsies were not collected at the same time. In total, we compared PCR 
results of 437 pairs of samples from 161 guinea pigs infected with R. rickettsii, 74 pairs of 
samples from 31 guinea pigs infected with R. parkeri, and 80 pairs of samples from 24 
guinea pigs infected with R. slovaca-like agent. Numbers of paired skin and blood samples 
tested at different time points post-infection varied from 1 to 42 depending on the pathogen 
and mode of infection (Fig. 1). Overall, rickettsial DNA was detected in 38.6% of skin 
samples and in 13.4% of blood samples. Rickettsial DNA was also detected in internal 
tissues, collected at the time of euthanasia 6–22 DPI, from 109 (67.7%), 24 (77.4%), and 9 
(37.5%) of the guinea pigs infected with R. rickettsii, R. parkeri, and R. slovaca-like agent 
respectively.
3.1. Detection of Rickettsia rickettsii in skin and blood samples
Out of 437 paired samples collected from R. rickettsii-infected guinea pigs for up to three 
weeks after infection, 173 (39.6%) of skin samples and 74 (16.9%) of blood samples 
contained rickettsial DNA detectable by PCR (p = 0.00017). The frequency of R. rickettsii 
detection in either skin or blood samples changed depending on the time post-infection; it 
was generally higher during the second week of infection (Fig. 2). In guinea pigs infected 
via tick bite, less than 25% of either blood or skin samples collected from infected animals 
yielded positive results during the first week post-exposure (Fig. 2A). At 9–17 DPI, 
rickettsial DNA was detected in 52–82% of skin samples, but only in 15–50% of blood 
samples. Frequency of detection declined again during the third week of infection. Still, 40–
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50% of skin samples were PCR-positive during this late period, while all blood samples 
collected at the same time were negative. Altogether in guinea pigs infected with R. 
rickettsii via tick bite, 35.7% of skin samples and 16.0% of blood samples collected in three 
weeks post-infection contained rickettsial DNA (p = 0.0017). Success of pathogen detection 
in guinea pigs infected via IP inoculation demonstrated similar dynamics (Fig. 2B). Again, 
the efficiency of pathogen detection was similarly low during the first week of infection, but 
from 7DPI onward the proportion of skin samples containing rickettsial DNA was 
consistently higher than that in blood samples. Thus, detection of R. rickettsii DNA in ear-
skin was significantly more frequent than in the blood collected from ear vein, even though 
skin samples were distant from the tick feeding site and not associated with a rash.
In guinea pigs infected with R. rickettsii, at least one of the samples – either skin or blood – 
was PCR-positive on 188 occasions out of 437 analyzed sample pairs. Among those 188, 
rickettsial DNA was detected 15 (8.0%) times in blood samples only, 59 (31.4%) times in 
both blood and skin samples, and 114 (60.6%) times only in skin samples. Thus, the overall 
concordance between two types of samples was low – less than one third of positive animals 
being identified simultaneously by both blood- and skin-PCR. Therefore, we evaluated how 
the concordance between sample types changes over the 3-wk duration of infection, and 
whether dual testing of both skin and blood samples may improve the chances for detection 
of the pathogen (Fig. 3). Both the concordance of results between types of samples and the 
added value of dual testing varied throughout the observation period. During the first 7–8 
DPI, the frequency of pathogen detection in either skin or blood was low, and the dual 
testing of both was the most beneficial. In fact, 24 (44%) and 10 (18.5%) out of the 54 
positive cases identified before 9 DPI would have been missed if we tested only blood or 
only skin sample respectively. The highest success in pathogen detection was recorded at 9–
17 DPI when R. rickettsii DNA was present in up to 60–70% of dual (skin + blood) samples 
collected from infected animals. During this period, the absolute majority (96.1%) of 
positive cases would have been successfully identified if just cutaneous samples had been 
tested. From 16 DPI to the end of the observation period, R. rickettsii DNA was detectable 
exclusively in skin biopsies, and additional testing of blood samples did not improve the 
diagnostic sensitivity (Fig. 3).
3.2. Detection of Rickettsia parkeri in skin and blood samples
Out of 74 skin biopsies collected from guinea pigs infected with R. parkeri, rickettsial DNA 
was detected in a total of 20 (27.0%) samples. In particular, 9 of 52 (17.3%) and 11 of 22 
(50%) of tested skin samples were PCR-positive in animals infected via tick bite and IP-
inoculation respectively. In contrast, all 74 blood samples were PCR-negative (p = 0.0002). 
The frequency of R. parkeri detection in cutaneous samples fluctuated significantly from one 
day to another (Fig. 4) due to low numbers of samples tested on any individual day 
postinfection. Still, in inoculated guinea pigs, the highest percentage of PCR-positive results 
was recorded at 5–7 DPI; it was highest (3 of 6) on 10 DPI in those exposed to infected 
ticks. Overall, 27–50% of skin biopsies were PCR-positive if collected between days 4 and 
13 after infection.
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3.3. Detection of Rickettsia slovaca-like agent in skin and blood samples
A total of 80 paired skin/blood samples were collected from 24 guinea pigs infected with R. 
slovaca-like agent via infestation with infected D. variabilis ticks. The presence of rickettsial 
DNA was confirmed in 26 (32.5%) skin samples and 5 (6.3%) blood samples (p = 0.0003). 
Although numbers of samples tested on each individual day are not sufficient to analyze 
temporal dynamics of rickettsial growth and distribution, it appears that the frequency of R. 
slovaca-like agent detection in skin biopsies was higher at 8–14 DPI (Fig. 5). During this 
period, rickettsial NDA was identified in 60% (3 of 5) to 100% (3 of 3) of samples. During 
the same period, detection of the same agent in blood was inconsistent and unpredictable – 
only 1 of 3 samples on days 9 and 14 (Fig. 5).
4. Discussion
Using guinea pigs experimentally infected with R. rickettsii, R. parkeri, and R. slovaca-like 
agent as model animals, we assessed whether rickettsial DNA can be detected in cutaneous 
biopsies not associated with inoculation eschars or the site of tick feeding; and compared the 
frequency of pathogen detection between skin and blood samples. Our results show that 
DNA of all three pathogens is routinely identifiable in skin biopsies during the acute stage of 
infection. This is true not only for R. rickettsii and R. parkeri, which engender recognizable 
clinical signs of illness, but also for the R. slovaca-like agent that consistently produces only 
subclinical infections in guinea pigs (Zemtsova et al. 2016). Moreover, chances for pathogen 
detection in skin are significantly higher than in blood, even though both types of samples 
have been collected simultaneously from the same ear, and despite the fact that the quantity 
of skin tissue represented in each PCR reaction (0.1 mg) was 50 times lower than that of the 
blood.
Based on the fact that the guinea pigs core body temperature is higher than that used for 
propagation of Rickettsia spp. in vitro (32–34 °C), it might be hypothesized that rickettsiae 
prefer to concentrate in the coolest tissues, namely the scrotum and ears. If this is true, then 
the ear should also be the most opportune site for detection of rickettsial DNA in other 
domestic and wild animals. At the same time, SFG rickettsiae are often found in internal 
organs collected postmortem from guinea pigs (this study), as well as from dogs (Levin et 
al., 2014) and humans (Walker et al., 1983; Walker and Gear 1985; Favacho et al., 2011). In 
dogs infected with either R. conorii or R. rickettsii, widespread abundant petechiae on gums 
and buccal mucosa developed in parallel with macular skin rash (Levin et al., 2012, 2014). 
Whether the rates of rickettsial growth in the endotelium of live animals is affected by 
temperature or not, it is logical to expect that chances for detection and identification of 
rickettsial pathogens in skin biopsies may be maximized by testing samples from finely 
vasculated sites, which have higher density of endothelial cells available for rickettsial 
proliferation.
The percentage of animals with identifiable DNA in either skin or blood vary in accordance 
with the prodromal, acute, and recovery phases of infection. In guinea pigs infected with R. 
rickettsii, percentage of PCR-positive skin sample was highest at 9–17 DPI, or 
approximately 4–10 days after the first appearance of fever. During that time, R. rickettsii 
DNA could be successfully identified in 60% to 80% of infected animals by testing of 
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biopsies. At the same time, chances for detection of R. rickettsii DNA in blood samples did 
not exceed 35–45% of infected animals. In guinea pigs infected with R. parkeri and R. 
slovaca-like agent, chances for detection of rickettsial DNA in skin samples during the peak 
of infection were as high as 33–66% and 60–100% respectively. On the contrary, R. slovaca-
like agent was found in only 5 (6.3%) blood samples widely and irregularly distributed 
throughout the period of observation, and R. parkeri DNA was not present in circulating 
blood at all. The much greater success of pathogen detection in skin is in agreement with the 
described predilection of SFG Rickettsia for endothelial cells. The route of infection did not 
affect the comparative diagnostic value of the two types of samples as the frequency of 
pathogen detection in blood remained lower than that in skin in animals infected with R. 
rickettsii or R. parkeri via tick-bite or intraperitoneal route.
Among the three pathogens used in this study, R. rickettsii was detected in blood samples 
more regularly than either R. parkeri or R. slovaca-like agent. It remains to be studied if this 
distinction is due to the virulence of different agents or to their preferred routes of 
dissemination throughout the organism. In infections caused by R. rickettsii, PCR results did 
not always correspond within blood and skin sample pairs. In approximately 61% of PCR-
positive sample pairs, rickettsial DNA was detectable in the skin only, while in 8% of sample 
pairs it was present only in the blood. Thus, testing of venous blood does add power to 
identification of R. rickettsii infections, although cutaneous samples provide a significantly 
higher sensitivity. The degree of incongruence between the sample types changes with the 
progression of illness. In the studied guinea pigs, this incongruence was the largest at 5–9 
DPI when up to 1/5 of the identified infections had positive blood-PCR, but negative skin-
PCR. This resulted in diagnosis of infection in approximately 5–10% cases in addition to 
those 18–52% already identifiable by testing of skin biopsies. The 5–9 DPI time period 
roughly coincides with the first appearance of fever in guinea pigs infected with the 
particular isolate of R. rickettsii (DI6) used in this study. This suggests that dual testing of 
both skin and blood samples may be beneficial for diagnosis of R. rickettsii infections at the 
time of appearance of the first nonspecific signs of illness. After that, infections can be 
successfully identified by skin-PCR only, and additional testing of blood samples may not 
improve detection and identification of R. rickettsii DNA.
Several species of tick-borne Rickettsia cause serious illness in humans. In particular, RMSF 
caused by R. rickettsii is a severe fast-progressing disease potentially leading to multi-organ 
failure unless antibiotic treatment is initiated within a week of the first signs of illness. In 
cases when diagnosis and appropriate treatment are delayed, RMSF can result in significant 
mortality. Yet, the initial signs and symptoms of rickettsial infections are nonspecific; 
several doctor visits are often required before the illness is diagnosed and appropriate 
treatment may be initiated. Molecular biological methods have the potential to expedite 
specific diagnosis of infection and rickettsial DNA have been successfully detected in eschar 
tissue or eschar swabs of patients with several SFG rickettsioses (Lakos 2002; Wang et al., 
2009; Bechah et al., 2011; Mouffok et al., 2011; Myers et al., 2013) or in biopsies of a skin 
rash (Kuloglu et al., 2012; Denison et al., 2014). However, R. rickettsii infections are rarely 
accompanied by an eschar (Walker et al., 1981; Chen and Sexton 2008), and a typical skin 
rash may not appear until later stages of illness, or not at all (Walker 1989; Sexton and 
Corey 1992; Favacho et al., 2011). To date, there are no published studies assessing 
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usefulness of skin biopsies not associated with eschars or sites of tick attachment for 
detection of SFG pathogens in either humans or animals.
Our analysis demonstrates that in model animals, DNA of R. rickettsii, R. parkeri, and R. 
slovaca-like agent can be identified by PCR in skin biopsies with significantly higher 
frequency compared to blood samples even if both are taken from the same ear. This 
confirms earlier suggestion that skin biopsy is more useful for detecting the SFG etiologic 
agent than an acute blood sample (Chapman et al., 2006). In guinea pigs with relatively mild 
or subclinical infections, R. rickettsii, R. parkeri, and R. slovaca-like agent DNAs is 
identified in up to 60–80%, 50–70%, and 60–100% of ear skin samples collected during the 
acute stage of infection respectively. Interestingly, the percentage of PCR-positive eschar 
and rash samples (70–73%) reported in human patients with Mediterranean spotted fever in 
Turkey was comparable to our results (Kuloglu et al., 2012). On the other hand, as the 
percentage of PCR-positive results appears to rise and fall in accord with the progress of 
infection, it may be that the frequency of detection of SFG rickettsial DNA in skin will be 
even higher in more severe cases. Although usefulness of skin biopsies for molecular 
diagnosis of SFG rickettsioses appear much greater than that of blood samples, the latter 
may somewhat add in rickettsial diagnosis during the early stages of infection.
Here, we analyzed the available data to compare sensitivity of rickettsial detection between 
blood and skin samples in guinea pigs only. To the best of our knowledge, comparable 
volumes of data characterizing either domestic and wild animal species or human patients 
are not available. Further studies in both animals and humans are needed to determine the 
best sites for specimen collection, improve the sensitivity of acute-stage diagnosis of 
rickettsial infections, as well as to find least invasive sampling techniques.
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Total numbers of paired skin and blood samples tested at different time points postinfection: 
A – from guinea pigs infected with R. rickettsii; B – from guinea pigs infected with R. 
parkeri; C k from guinea pigs infected with R. slovaca.
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Percent of PCR-positive skin and blood samples collected from R. rickettsii-infected guinea 
pigs: A k guinea pigs infected via tick bite; B – guinea pigs infected via IP inoculation.
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Proportions of skin and blood samples collected simultaneously from guinea pigs infected 
with R. rickettsii, where rickettsial DNA was identified at different time point after infection 
– the added value of dual testing.
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Percent of PCR-positive skin and blood samples collected from R. parkeri-infected guinea 
pigs.
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Percent of PCR-positive skin and blood samples collected from guinea pigs infected with R. 
slovaca-like agent via tick bite.
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